Clik here to view.
Medtronic legal counsel heads to greener pastures
Medtronic senior legal and compliance executive Cameron Findlay takes a job at crop management company Archer Daniels Midland, effective next month.Medtronic (NYSE:MDT) legal chief Cameron Findlay is...
View ArticleClik here to view.
CardioFocus launches new E.U. trial of HeartLight ablation system
CardioFocus touts the launch of a new multi-center European clinical trial evaluating its HeartLight endoscopic ablation system in treatment of patients with persistent atrial...
View ArticleClik here to view.
Medtronic's latest pain pump warnings get FDA's Class I status
Three of the 4 warnings that Medtronic issued over its SynchroMed implantable pain pumps get the FDA's highest-risk label for their potential to harm patients.Medical device giant Medtronic (NYSE:MDT)...
View ArticleClik here to view.
HBA panel: True healthcare reform requires a better connection to patients
Panelists at the 2nd annual Healthcare Businesswomen's Assn. conference say successful healthcare reform will remain out of reach until professionals truly understand what patients want.Four women...
View ArticleClik here to view.
FDA releases April 2013 PMA approvals
The U.S. Food & Drug Administration releases a list of pre-market approvals granted in April 2013.Total Under Review: 50 Total Active:15 Total On Hold: 35 Summary of PMA Supplements Under Review...
View ArticleClik here to view.
St. Jude's Amplatzer looks better in new analysis
St. Jude Medical says that patients implanted - and fitted - with its Amplatzer patent foramen ovale closure device showed benefits not seen in the larger trial.Medical device giant St. Jude Medical...
View ArticleClik here to view.
St. Jude Medical launches MRI-safe pacemaker system in Japan
St. Jude won a regulatory green-light in Japan for the 1st commercially available pacemaker and lead system safe during an MRI.St. Jude Medical won approval in Japan for the 1st commercially available...
View ArticleClik here to view.
Podcast: Medtronic CEO Omar Ishrak on emerging markets, economic value and...
Medtronic CEO Omar Ishrak speaks with MassDevice.com publisher Brian Johnson about an evolving global medical device landscape, the shifting values of consumers and why he’s not too worried about...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for June 27, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of...
View ArticleClik here to view.
E.U. regulators dishing out fewer CE Marks, study finds | MassDevice.com On Call
The European Assn. for Medical Devices of Notified Bodies says that the number of new CE Mark certificates have dropped significantly in recent years.MASSDEVICE ON CALL — European regulators have...
View ArticleClik here to view.
Do we have enough manufacturing talent?
For the last decade, no executives have had their passports stamped more often than VPs of Manufacturing. That’s because many companies, especially those that manufacture complex products, have been...
View ArticleClik here to view.
Middle Peak raises $8.5M for mitral valve implant
Middle Peak Medical raises $8.5 million to develop its mitral valve replacement technology.Middle Peak Medical said it raised an $8.5 million Series A round to develop its technology for mitral valve...
View ArticleClik here to view.
C.R. Bard deals electrophysiology biz to Boston Scientific
C.R. Bard says it's agreed to sell its electrophysiology business to rival Boston Scientific for $275 million.News Well, Cardiac Rhythm Management, Mergers & Acquisitions, Wall Street Beatread more
View ArticleClik here to view.
Federal Circuit again invalidates Cordis patent claims against Medtronic,...
Johnson & Johnson subsidiary Cordis Corp. and Pfizer subsidiary Wyeth Pharma. fail to reserve a lower court's rulings invalidating patents for drug-eluting coronary stent technology.A trio of...
View ArticleClik here to view.
Women's health: Smith & Nephew win over Hologic stands, damages TBD
A federal judge in Massachusetts upholds a $4 million Smith & Nephew patent infringement win over Hologic's MyoSure fibroid surgery device, but rules that a jury's verdict was too vague to...
View ArticleClik here to view.
Shipping up to Boston: Johnson & Johnson debuts new Innovation Center
Johnson & Johnson celebrates the grand opening of its latest Innovation Center in Massachusetts, where the healthcare giant aims to tap into Boston's biotech start-up culture.Johnson & Johnson...
View ArticleClik here to view.
Aethlon wins FDA approval for Hemopurifier blood filter trial
Aethlon Medical wins an investigational device exemption from the FDA for a trial of its Hemopurifier blood filter.Aethlon Medical (OTC:AEMD) said the FDA granted an investigational device exemption...
View ArticleClik here to view.
AngioDynamics wins clearances in the U.S., Canada
AngioDynamics touts regulatory wins in the U.S. and Canada for its vascular port products.AngioDynamics (NSDQ:ANGO) celebrated 2 regulatory wins this week, an FDA 510(k) clearance for its Xcela Plus...
View ArticleClik here to view.
Second Sight launches U.S. centers for 'bionic eye'
Second Sight Medical opens 12 U.S. centers for its "bionic eye" Argus II retinal implant.Second Sight Medical is slated to set up shop at 12 medical centers across the U.S. to begin consultations for...
View ArticleClik here to view.
Safeguard Scientifics managing director Datin resigns
Executive vice president and managing director James Datin quits after 8 years with Safeguard Scientifics.James Datin gave his notice as executive vice president and managing director to Safeguard...
View Article
